drugset / Trial / NCT03383471

The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis

NCT03383471 ↗

Phase 3 Unknown 146 enrolled Kolon Life Science
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of intraarticular Invossa K Injection patients diagnosed with Kellgren \& Lawrence grade 2 knee osteoarthritis.

Timeline

Start
2018-02-12
Primary completion
2019-12-31
Completion
2020-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Invossa K Inj. Unknown — Other

Indications